Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/15118
DC FieldValueLanguage
dc.contributor.authorStreit, Svenen_US
dc.contributor.authorVerschoor, Marjoleinen_US
dc.contributor.authorRodondi, Nicolasen_US
dc.contributor.authorBonfim, Daianaen_US
dc.contributor.authorBurman, Robert Aen_US
dc.contributor.authorCollins, Claireen_US
dc.contributor.authorGerasimovska Kitanovska Biljanaen_US
dc.contributor.authorGintere, Sandraen_US
dc.contributor.authorGómez Bravo, Raquelen_US
dc.contributor.authorHoffmann, Kathrynen_US
dc.contributor.authorIftode, Claudiaen_US
dc.contributor.authorJohansen, Kasper Len_US
dc.contributor.authorKerse, Ngaireen_US
dc.contributor.authorKoskela, Tuomas Hen_US
dc.contributor.authorPeštić, Sanda Kreitmayeren_US
dc.contributor.authorKurpas, Donataen_US
dc.contributor.authorMallen, Christian Den_US
dc.contributor.authorMaisoneuve, Huberten_US
dc.contributor.authorMerlo, Christophen_US
dc.contributor.authorMueller, Yolandaen_US
dc.contributor.authorMuth, Christianeen_US
dc.contributor.authorŠter, Marija Peteken_US
dc.contributor.authorPetrazzuoli, Ferdinandoen_US
dc.contributor.authorRosemann, Thomasen_US
dc.contributor.authorSattler, Martinen_US
dc.contributor.authorŠvadlenková, Zuzanaen_US
dc.contributor.authorTatsioni, Athinaen_US
dc.contributor.authorThulesius, Hansen_US
dc.contributor.authorTkachenko, Victoriaen_US
dc.contributor.authorTorzsa, Peteren_US
dc.contributor.authorTsopra, Rosyen_US
dc.contributor.authorCanan, Tuzen_US
dc.contributor.authorViegas, Rita P Aen_US
dc.contributor.authorVinker, Shlomoen_US
dc.contributor.authorde Waal, Margot W Men_US
dc.contributor.authorZeller, Andreasen_US
dc.contributor.authorGussekloo, Jacobijnen_US
dc.contributor.authorPoortvliet, Rosalinde K Een_US
dc.date.accessioned2021-10-07T10:20:40Z-
dc.date.available2021-10-07T10:20:40Z-
dc.date.issued2017-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/15118-
dc.description.abstractIn oldest-old patients (>80), few trials showed efficacy of treating hypertension and they included mostly the healthiest elderly. The resulting lack of knowledge has led to inconsistent guidelines, mainly based on systolic blood pressure (SBP), cardiovascular disease (CVD) but not on frailty despite the high prevalence in oldest-old. This may lead to variation how General Practitioners (GPs) treat hypertension. Our aim was to investigate treatment variation of GPs in oldest-olds across countries and to identify the role of frailty in that decision.en_US
dc.language.isoenen_US
dc.publisherBMC Part of Springer Natureen_US
dc.relation.ispartofBMC Geriatricsen_US
dc.titleVariation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countriesen_US
dc.typeArticleen_US
dc.identifier.doi10.1186/s12877-017-0486-4-
dc.identifier.urlhttp://link.springer.com/content/pdf/10.1186/s12877-017-0486-4.pdf-
dc.identifier.volume17-
dc.identifier.issue1-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

26
checked on Jul 24, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.